Table 1.
Baseline characteristics
|
Normal glucose group |
Median glucose group |
High glucose group |
|
|---|---|---|---|
| (n = 33) | (n = 24) | (n = 26) | |
| Age (y) |
58 ± 11 |
61 ± 10 |
59 ± 11 |
| Male (%) |
28 (84.8%) |
20 (83.3%) |
18 (69.2%) |
| BMI (kg/m2) |
25.3 ± 1.8 |
25.0 ± 2.7 |
25.7 ± 2.5 |
|
Medical history | |||
| Hypertension, n (%) |
20 (60.6%) |
19 (79.2%) |
21 (80.8%) |
| Previous diabetes, n (%) |
2 (6.1%) |
6 (25.0%) |
12 (46.2%)* |
| Previous angina, n (%) |
5 (15.1%) |
3 (12.5%) |
3 (11.5%) |
| Atrial fibrillation, n (%) |
0 (0%) |
0 (0%) |
1 (3.8%) |
| Current smoker, n (%) |
21 (63.3%) |
15 (62.5%) |
20 (76.9%) |
|
Biochemical data | |||
| Cholesterol (mmol/L) |
4.81 ± 0.85 |
4.46 ± 1.13 |
4.80 ± 1.21 |
| LDL-cholesterol (mmol/L) |
2.78 ± 0.68 |
2.57 ± 0.75 |
2.78 ± 0.83 |
| HDL-cholesterol (mmol/L) |
1.02 ± 0.22 |
0.95 ± 0.26 |
0.96 ± 0.21 |
| Triglycerides (mmol/L) |
1.31 ± 0.65 |
1.27 ± 0.83 |
1.98 ± 1.42* |
| hsCRP (mg/L) |
3.2 ± 2.8 |
2.3 ± 1.6 |
3.7 ± 4.5 |
| CKMB (IU/L) |
137.9 ± 96.9 |
145.7 ± 85.5 |
100.6 ± 89.5 |
| Creatinine (μmol/L) |
91.48 ± 29.34 |
85.04 ± 26.74 |
96.15 ± 19.31 |
| GFR (ml/min) |
78.22 ± 24.28 |
79.43 ± 27.45 |
70.90 ± 15.85 |
| HbA1C (%) |
4.5 ± 1.1 |
5.3 ± 1.2† |
7.6 ± 2.0*, # |
| Admission plasma glucose level (mmol/L) |
6.3 ± 0.9 |
9.1 ± 0.9† |
14.5 ± 3.4*, # |
|
Clinical aspects of STEMI | |||
| Ischemia time | |||
| Symptom-to-enrollement, min |
355 ± 162 |
340 ± 151 |
346 ± 180 |
| Symptom-to-ballon, min |
419 ± 159 |
409 ± 149 |
414 ± 183 |
| Infarct site: Anterior |
51.5% |
54.2% |
57.7% |
| Infarct related artery | |||
| LAD, n (%) |
18 (55%) |
11 (46%) |
13 (50%) |
| LCX, n (%) |
3 (9%) |
3 (13%) |
3 (11%) |
| RCA, n (%) |
12 (36%) |
10 (42%) |
10 (38%) |
| Number of diseased vessels | |||
| 1 coronary vessel (%) |
23 (70%) |
17 (71%) |
16 (62%) |
| 2 coronary vessels (%) |
8 (24%) |
6 (25%) |
8 (31%) |
| 3 coronary vessels (%) |
2 (6%) |
1 (4%) |
2 (7%) |
| Number of stent implanted |
1.48 ± 0.51 |
1.58 ± 0.50 |
1.50 ± 0.51 |
| Stent type | |||
| Bare-metal stent, (%) |
44% |
39% |
38% |
| Drug-eluting stent, (%) | 56% | 61% | 62% |
BMI body mass index; HDL high-density lipoprotein; hsCRP high-sensitivity C-reactive protein; LDL low-density lipoprotein; CKMB creatine kinase isoenzyme MB; GFR glomerular filtration rate; HbA1C glycosylated hemoglobin;
*P < 0.05 for the high glucose group versus the normal glucose group.
#P < 0.05 for the high glucose group versus the median glucose group.
†P < 0.05 for the median glucose group versus the normal glucose group.